« Le pronostic de Jalen Lesage est très bon, et nous nous attendons à un rétablissement complet », indicated a joint statement issued by agent Nicole Lynn and the Philadelphia Eagles regarding the medical condition ending the quarterback’s season.
Philadelphia Quarterback Jalen Hurts Sidelined by Multiple Lung Blood Clots
Philadelphia Eagles quarterback Jalen Hurts will miss the remainder of the National Football League season after medical examinations revealed multiple blood clots in his lungs, according to reports from Ian Rapoport of NFL Network and Adam Schefter of ESPN. The diagnosis marks a dramatic escalation from an initial finding of a superficial calf clot that led to a six-week stint on the injured reserve list. Subsequent radiological examinations uncovered a deep vein thrombosis alongside bilateral pulmonary embolisms, forcing medical staff to alter their treatment approach.
Rapoport reported that Hurts will undergo a regimen of anticoagulant therapy lasting at least three months. Nicole Lynn, the player’s agent, and the Eagles released a joint statement Monday detailing the quarterback’s clinical status and outlining the necessary precautions required during recovery. Medical protocols dictate a total cessation of contact sports while taking blood thinners, as even minor impacts can lead to severe internal hemorrhaging.
Medical Status and Treatment Protocols Outlined by Team and Management
According to the statement from Lynn and the franchise, Hurts remains clinically stable and exhibits no significant functional limitations. However, team physicians will not permit him to participate in any football-related activities while he remains on anticoagulant medication. The therapeutic course aims to systematically dissolve the blood clusters safely over the upcoming quarter-year.
« Nous prévoyons qu’il pourra reprendre les activités de football impliquant des contacts une fois qu’il ne prendra plus d’anticoagulants », the statement noted, adding that the quarterback will remain active within the organization and continue non-contact training. Medical specialists anticipate no long-term physical sequelae, projecting a full return to competitive play once the medication cycle concludes and clearance is granted.
Roster Adjustments and Recent Team Performance Impacted in Philadelphia
The sudden loss of Hurts compounds a difficult stretch for the Philadelphia Eagles, whose season has been marred by injuries, retirements, and fluctuating on-field performances. The franchise now turns its offense over to backup quarterback Tanner McKee, who stepped into the starting role immediately following the initial diagnosis.
McKee made his first start during an outing that ended in a defeat, completing 26 of 45 pass attempts for 215 yards and one touchdown, as reported by Touchdown Actu. The publication also noted that the ongoing situation has intensified league-wide conversations regarding player safety protocols and franchise oversight, referencing earlier reports surrounding the physical risks managed during the team’s recent international fixture in London.
Worth a look
